Kevin Waters Procept Bio Robotics Corp (PRCT) insider trading activity

Kevin Waters is EVP, CFO of PROCEPT BioRobotics Corp. Currently has a direct ownership of 102,149 shares of PRCT, which is worth approximately $6.78 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 1,024 shares (Common Stock) at a price of $48.83 per share, resulting in proceeds of $50,001. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K

204.71% 3M change

81.91% 12M change

Total Value Held $6.78 Million

Kevin Waters Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2024	SELL Open market or private sale	$50,001 $48.83 p/Share	1,024 Reduced 0.99%	102,149 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	$244,056 $4.54 p/Share	53,757 Added 34.26%	103,173 Common Stock
Mar 06 2024	SELL Open market or private sale	$160,311 $46.67 p/Share	3,435 Reduced 6.5%	49,416 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	19,328 Added 26.78%	52,851 Common Stock
Feb 12 2024	SELL Open market or private sale	$1,121,025 $50.16 p/Share	22,349 Reduced 40.0%	33,523 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	$101,017 $4.52 p/Share	22,349 Added 28.57%	55,872 Common Stock
Feb 09 2024	SELL Open market or private sale	$1,436,430 $50.09 p/Share	28,677 Reduced 46.1%	33,523 Common Stock

Feb 09 2024	BUY Exercise of conversion of derivative security	$129,620 $4.52 p/Share	28,677 Added 31.56%	62,200 Common Stock
Feb 07 2024	SELL Open market or private sale	$45,200 $50.0 p/Share	904 Reduced 2.63%	33,523 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	$4,086 $4.52 p/Share	904 Added 2.56%	34,427 Common Stock
Jan 09 2024	SELL Open market or private sale	$780,161 $45.07 p/Share	17,310 Reduced 34.05%	33,523 Common Stock
Jan 09 2024	BUY Exercise of conversion of derivative security	$78,241 $4.52 p/Share	17,310 Added 25.4%	50,833 Common Stock
Dec 13 2023	SELL Open market or private sale	$2,862,173 $40.05 p/Share	71,465 Reduced 68.07%	33,523 Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	$323,021 $4.52 p/Share	71,465 Added 40.5%	104,988 Common Stock
Dec 08 2023	SELL Open market or private sale	$275,657 $40.02 p/Share	6,888 Reduced 17.04%	33,523 Common Stock
Dec 08 2023	BUY Exercise of conversion of derivative security	$31,133 $4.52 p/Share	6,888 Added 12.41%	48,608 Common Stock
Dec 07 2023	SELL Open market or private sale	$153,480 $40.0 p/Share	3,837 Reduced 8.67%	40,411 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$17,343 $4.52 p/Share	3,837 Added 8.42%	41,720 Common Stock
Dec 06 2023	SELL Open market or private sale	$174,487 $40.02 p/Share	4,360 Reduced 8.97%	44,248 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$19,707 $4.52 p/Share	4,360 Added 10.32%	37,883 Common Stock
Jun 15 2023	SELL Open market or private sale	$794,800 $35.12 p/Share	22,631 Reduced 40.3%	33,523 Common Stock
Mar 16 2023	SELL Open market or private sale	$22,479 $31.84 p/Share	706 Reduced 1.24%	56,154 Common Stock
Mar 08 2023	SELL Open market or private sale	$757,500 $34.36 p/Share	22,046 Reduced 27.65%	57,678 Common Stock
Mar 07 2023	SELL Open market or private sale	$275,685 $34.66 p/Share	7,954 Reduced 12.27%	56,860 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	26,315 Added 23.25%	86,860 Common Stock

Kevin Waters

EVP, CFO

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRCT shares.

Notify only if

Value

Insider Trading

Get notified when an Procept Bio Robotics Corp insider buys or sells PRCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PROCEPT BioRobotics Corp

Track Activities on PRCT

Account